Importance of the field: The active suppression of immune responses against tumor is a major
barrier to the likely success of cancer immunotherapy. There is now compelling evidence …

… In addition, special focus has been given on the efficient application of lncRNAs as
potential targets for therapeutics that holds a great promise for future cancer therapy. …

… 1 illustrates the biochemical basis of cancer chemopreventive and therapeutic potential of
resveratrol. The chemopreventive property of resveratrol has been reflected by its ability to …

… has inspired great interest in exploring therapeutic potentials by targeting the UPR … in
cancer therapy. In the following, we provide some representative evidence for cancer therapeutic …

… applications to cancer therapy. This has led to the identification of PEDF as a major antagonist
to angiogenic factors (such as vascular endothelial growth factor (VEGF)), evidence for its …

… What the reader will gain: This review enables the reader to overview current knowledge
about FAK inhibition in cancer therapy and its role in the clinical setting. The reader will be able …

… We additionally highlight the side effects associated with HDACi in cancer therapy and
discuss potential biomarkers to either select or predict a patient’s response to these agents, in …

… , as well as their biological functions in cancer. Promising agents that use or target the
GRPs are being developed, and their efficacy as anticancer therapeutics is also discussed. …

The incidence of breast cancer continues to rise: 1.7 million women were diagnosed with
and 521,000 women died from breast cancer in 2012. This review considers first current …

… These three therapeutic approaches are named by the experts as ‘the pillars of cancer therapy’…
The concept of single therapy in cancer therapy has been discounted with each discovery …